The data-only access process will provide immediate access to currently available data, corresponding to genome-wide genotyping associated with clinical data on more than 500 samples from the BQC19, divided between SARS-CoV-2 positive participants and case controls.

The data and sample access process will provide access to samples, as well as clinical and analytical data from all BQC19 participants, after the processing of requests is complete in February 2021.

To submit an access request before the deadline of November 16, 2020, CLICK HERE.

For any request for information on the access process, please contact acces à